- $134.13bn
- $449.02bn
- $25.52bn
- 59
- 40
- 95
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11,785 | 12,109 | 18,996 | 22,307 | 25,521 |
Cost of Revenue | |||||
Gross Profit | 10,721 | 11,691 | 18,520 | 20,762 | 18,837 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,937 | 7,809 | 11,283 | 12,919 | 19,143 |
Operating Profit | 4,848 | 4,300 | 7,713 | 9,388 | 6,378 |
Net Income Before Taxes | 4,848 | 4,300 | 7,713 | 9,388 | 6,378 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,704 | 3,299 | 5,855 | 7,183 | 5,067 |
Net Income Before Extraordinary Items | |||||
Net Income | 3,704 | 3,299 | 5,855 | 7,183 | 5,067 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3,526 | 3,043 | 5,584 | 6,872 | 4,779 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.67 | 2.54 | 2.93 | 3.58 | 3.28 |
Dividends per Share |